Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme.

@article{Quan2004EpidermalGF,
  title={Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme.},
  author={Aimee L Quan and Gene H. Barnett and Sung churl Lee and Michael A. Vogelbaum and Steven A Toms and Susan M. Staugaitis and Richard A. Prayson and David M. Peereboom and Glen Harold John Stevens and Bruce H. Cohen and Jin Hyung Suh},
  journal={International journal of radiation oncology, biology, physics},
  year={2004},
  volume={63 3},
  pages={
          695-703
        }
}
PURPOSE There have been conflicting reports in the literature regarding the prognostic significance of epidermal growth factor receptor (EGFR) amplification in patients with glioblastoma multiforme (GBM). The purpose of this study is to determine the prognostic significance of EGFR amplification in patients with GBM treated at the Cleveland Clinic Foundation. METHODS AND MATERIALS A retrospective review of GBM patients treated with surgery at the Cleveland Clinic Foundation was performed… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 27 CITATIONS

Similar Papers

Loading similar papers…